Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone661-367-9170
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$534,034.00
Profitability
Miscellaneous
Employees55
Next Earnings DateN/A
OptionableOptionable
Avita Medical (ASX:AVH) Frequently Asked Questions
What is Avita Medical's stock symbol?
Avita Medical trades on the ASX under the ticker symbol "AVH."
How were Avita Medical's earnings last quarter?
Avita Medical Ltd (ASX:AVH) released its quarterly earnings results on Thursday, February, 28th. The company reported ($0.02) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.01) by $0.01. View Avita Medical's Earnings History.
Has Avita Medical been receiving favorable news coverage?
Media stories about AVH stock have been trending extremely negative on Friday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Avita Medical earned a news impact score of -4.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Avita Medical.
Who are some of Avita Medical's key competitors?
Some companies that are related to Avita Medical include ConvaTec Group (CTEC), Stratec (SBS), Draegerwerk AG & Co KGaA (DRW3), Zynex (ZYXI), Creo Medical Group (CREO), Medica Group (MGP), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Hamilton Thorne (HTL), Electromed (ELMD), Electromed (ELMD), Advanced Oncotherapy (AVO), Cyclopharm (CYC), Kromek Group (KMK), MRI Interventions (MRIC) and Patient Home Monitoring (PTQ).
What other stocks do shareholders of Avita Medical own?
Who are Avita Medical's key executives?
Avita Medical's management team includes the folowing people:
- Dr. Michael S. Perry, CEO & Director (Age 60)
- Mr. Dale A. Sander, Chief Financial Officer (Age 59)
- Mr. Timothy Rooney, Chief Admin. Officer
- Mr. Andrew Quick, Sr. VP of Clinical Devel.
- Ms. Erin Liberto, Chief Commercial Officer
What is Avita Medical's stock price today?
One share of AVH stock can currently be purchased for approximately A$0.77.
How big of a company is Avita Medical?
What is Avita Medical's official website?
How can I contact Avita Medical?
The company can be reached via phone at 661-367-9170.
MarketBeat Community Rating for Avita Medical (ASX AVH)
MarketBeat's community ratings are surveys of what our community members think about Avita Medical and other stocks. Vote "Outperform" if you believe AVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
